Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial [NA]

View source ↗

Summary

A TEA TIME trial from Mount Sinai Hospital (Canada) is evaluating time-restricted eating for Type 2 diabetes and metabolic health, and recruitment is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Type 2 Diabetes, Overweight (BMI > 25) | NA | Status: RECRUITING